Further investigations established a correlation between HAGLR expression and adverse clinical features like lymph node metastasis, larger tumors, advanced TNM stages, and poor patient prognosis in GC. The gene discussed is HAGLR; the disease is metastatic malignant neoplasm in the lymph nodes.